Nephrotect (Valine, Acetylcysteine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine)

• Nephroprotect is an intravenous amino‑acid formulation that may be employed to support renal health and metabolic needs in various clinical contexts.
• Adjunctive therapy in renal replacement therapy: provides essential amino acids to maintain plasma protein synthesis during dialysis.
• Peri‑operative renal protection: supplementation may help mitigate amino‑acid depletion associated with major surgery and improve postoperative recovery.
• Chronic kidney disease nutritional support: assists in preserving nitrogen balance when oral intake is insufficient or restricted.

• The amino‑acid blend supplies substrates for protein synthesis, glutathione production, and nitric‑oxide generation. Valine, leucine and isoleucine activate the mTOR pathway, promoting cellular growth, while acetylcysteine serves as a cysteine donor for antioxidant defenses. Arginine contributes to vasodilation via nitric‑oxide synthase, and other essential amino acids support metabolic processes essential for renal cell function. These combined actions help replenish depleted pools and protect renal tubular cells from oxidative stress.

Nephroprotect, like other intravenous amino‑acid solutions, may be associated with a range of adverse reactions.

Common Side Effects

• Infusion site erythema: localized redness or mild swelling at the injection site.
• Transient nausea: brief feeling of nausea during or shortly after infusion.
• Mild hypotension: temporary drop in blood pressure, often asymptomatic.
• Headache: mild to moderate headache occurring during treatment.

Serious or Rare Side Effects

• Anaphylactic reaction: severe allergic response requiring immediate medical intervention.
• Severe hyperammonemia: elevated blood ammonia levels leading to neurological symptoms.
• Metabolic acidosis: significant acid‑base disturbance requiring correction.
• Renal tubular injury: rare direct toxicity to renal tubules manifesting as impaired function.

Prior to administering Nephroprotect, clinicians should observe several safety precautions to minimize risk.

• Assess renal function: evaluate baseline creatinine and electrolyte status before infusion.
• Monitor infusion rate: administer slowly to reduce risk of hypotension and related events.
• Check for hypersensitivity: discontinue immediately if signs of allergy such as rash or bronchospasm appear.
• Avoid in severe hepatic impairment: risk of ammonia accumulation may be heightened.
• Review concomitant nephrotoxic drugs: adjust therapy when used with agents like aminoglycosides or contrast media.
• Store at ambient temperature: keep in original container, protect from light and moisture.

Nephroprotect may interact with certain medications; awareness of these interactions assists in safe co‑administration.

Major Interactions (Avoid)

• Concurrent high‑dose N‑acetylcysteine: may cause excessive sulfhydryl load and renal stress.
• Co‑administration with aminoglycoside antibiotics: increased risk of nephrotoxicity.
• Combination with valproate or other ammonia‑raising agents: potential for severe hyperammonemia.

Moderate Interactions (Monitor Closely)

• Use with intravenous lipid emulsions: may alter amino‑acid distribution and plasma levels.
• Concomitant diuretics: monitor electrolytes and fluid balance closely.
• Vitamin B6 supplementation: may affect metabolism of certain amino acids, requiring observation.